title: The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi.
abstract: We report a large study of the effect of BCG vaccination on the in vitro 6-day whole blood interferon-gamma (IFN-gamma) response to antigens from eight species of mycobacteria among schoolchildren in south-eastern England, where bacille Calmette-Guérin (BCG) vaccination is highly protective against pulmonary tuberculosis, and among young adults in northern Malawi, where BCG vaccination is not protective. In the UK children, BCG induced an appreciable increase in IFN-gamma response to antigens from most species of mycobacteria. The degree of change was linked to the relatedness of the species to Mycobacterium bovis BCG, and provides further evidence of the cross-reactivity of mycobacterial species in priming of the immune system. IFN-gamma responses to purified protein derivatives (PPDs) from M. tuberculosis and environmental mycobacteria were more prevalent in the Malawian than the UK group prior to vaccination; BCG vaccination increased the prevalence of responses to these PPDs in the UK group to a level similar to that in Malawi. There was no evidence that the vaccine-induced change in IFN-gamma response was dependent upon the magnitude of the initial response of the individual to environmental mycobacteria in the United Kingdom or in Malawi. These observations should assist the development and interpretation of human clinical trials of new vaccines against M. tuberculosis in areas of both low and high exposure to environmental mycobacteria.
authors.affiliation: Department of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK.
authors.forename: R E
authors.initials: RE
authors.lastname: Weir
authors.forename: G F
authors.initials: GF
authors.lastname: Black
authors.forename: B
authors.initials: B
authors.lastname: Nazareth
authors.forename: S
authors.initials: S
authors.lastname: Floyd
authors.forename: S
authors.initials: S
authors.lastname: Stenson
authors.forename: C
authors.initials: C
authors.lastname: Stanley
authors.forename: K
authors.initials: K
authors.lastname: Branson
authors.forename: L
authors.initials: L
authors.lastname: Sichali
authors.forename: S D
authors.initials: SD
authors.lastname: Chaguluka
authors.forename: L
authors.initials: L
authors.lastname: Donovan
authors.forename: A C
authors.initials: AC
authors.lastname: Crampin
authors.forename: P E M
authors.initials: PE
authors.lastname: Fine
authors.forename: H M
authors.initials: HM
authors.lastname: Dockrell
mesh_terms: D000293:Adolescent; D000942:Antigens, Bacterial / Q000276:immunology; D001500:BCG Vaccine / Q000276:immunology*; D003429:Cross Reactions; D004739:England; D005260:Female; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis*; D008295:Malawi; D008297:Male; D009161:Mycobacterium / Q000145:classification / Q000276:immunology; D009164:Mycobacterium Infections / Q000276:immunology*; D013045:Species Specificity; D014373:Tuberculin / Q000276:immunology; D014611:Vaccination
chemical_list: D000942:Antigens, Bacterial; D001500:BCG Vaccine; D014373:Tuberculin; D007371:Interferon-gamma